Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Prophylaxis of Graft-Versus-Host Disease (GVHD) with Pentostatin, Tacrolimus, and “Mini”-Methotrexate (MTX): A Phase I/II Controlled, Randomized Study in Unrelated Donor (UD) Transplantation.

Blood (2007) 110 (11): 40.

https://doi.org/10.1182/blood.V110.11.40.40

Published: 2007

Journal Articles

Higher Rate of Thrombotic Thrombocytopenic Pupura (TTP) Associated with Graft Versus Host Disease (GVHD) and Unrelated Donor Bone Marrow Transplantation (BMT).

B. Oran, MD, A. Aleman, MD, E. J. Shpall, MD, C. Hosing, MD, M. Korbling, MD, P. Anderlini, MD, R. Champlin, MD, M. Donato, MD

Blood (2005) 106 (11): 1111.

https://doi.org/10.1182/blood.V106.11.1111.1111

Published: 2005

Journal Articles

Unrelated-Donor PBSC Collection Facilitated by the NMPD, 1999–2005: Efficacy and Toxicities, Serious Unexpected Events, and Outcomes of Standard vs. Large Volume Collections.

Michael Pulsipher, S. Kurian, S. F. Leitman, P. Anderlini, M. Haagenson, B. Logan, M. M. Horowitz, D. L. Confer

Blood (2005) 106 (11): 1965.

https://doi.org/10.1182/blood.V106.11.1965.1965

Published: 2005

Journal Articles

Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) with Fludarabine and Melphalan (FM) Reduced Intensity Conditioning (RIC) for High-Risk AML/MDS.

B. Oran, R. Saliba, S. Giralt, D. Couriel, A. Carrasco-Yalan, C. Hosing, M. Shahjahan, E. de Meis, A. Anagnostopoulos, P. Anderlini, S. Ghosh, I. Khouri, R. Champlin, M. de Lima

Blood (2005) 106 (11): 838.

https://doi.org/10.1182/blood.V106.11.838.838

Published: 2005

Journal Articles

Results of a Phase I/II Study of Gemtuzumab Ozogamicin Added to Fludarabine (F), Melphalan (M) and Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Relapsed Myeloid Leukemias.

Marcos de Lima, S. Giralt, Z. Caldera, G. McCormick, M. Qazilbash, P. Anderlini, E. J. Shpall, C. Hosing, M. Donato, S. Kornblau, I. Khouri, T. Martin, D. Couriel, R. Champlin

Blood (2005) 106 (11): 841.

https://doi.org/10.1182/blood.V106.11.841.841

Published: 2005

Journal Articles

Pentostatin, Tacrolimus, and “Mini”-Methotrexate for Graft-Versus-Host Disease (GVHD) Prophylaxis: A Phase I/II Controlled, Randomized Study.

M. de Lima, D. Couriel, M. Munsell, M. Westmoreland, H. Shah, J. deJesus, C. Hosing, S. Ghosh, P. Anderlini, J. Gajewski, B. Andersson, S. Kornblau, B. Hocking, C. Ippoliti, S. Giralt, E. Shpall, R. Champlin

Blood (2004) 104 (11): 727.

https://doi.org/10.1182/blood.V104.11.727.727

Published: 2004

Journal Articles

Phase I/II Study of Gemtuzumab Ozogamicin (GO), Fludarabine and Melphalan (FM) Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in AML/MDS.

M. de Lima, P. Thall, M. Shahjahan, W. Xuemei, D. Couriel, P. Anderlini, C. Hosing, M. Qazilbash, G. McCormick, C. Ippoliti, M. Donato, T. Martin, L. Metoyer, L. Griffin, P. Kebriaei, R. Champlin, S. Giralt

Blood (2004) 104 (11): 1824.

https://doi.org/10.1182/blood.V104.11.1824.1824

Published: 2004

Journal Articles

Peripheral blood stem cell apheresis in normal donors: the neglected side [letter; comment]

P Anderlini, D Przepiorka, R Champlin, M Korbling

Blood (1996) 88 (9): 3663–3664.

https://doi.org/10.1182/blood.V88.9.3663.bloodjournal8893663

Published: 1996

Journal Articles

Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals

P Anderlini, D Przepiorka, R Champlin, M Korbling

Blood (1996) 88 (8): 2819–2825.

https://doi.org/10.1182/blood.V88.8.2819.bloodjournal8882819

Published: 1996

Journal Articles

Treatment of chronic myelogenous leukemia: current status and investigational options [see comments]

HM Kantarjian, S O'Brien, P Anderlini, M Talpaz

Blood (1996) 87 (8): 3069–3081.

https://doi.org/10.1182/blood.V87.8.3069.bloodjournal8783069

Published: 1996

Journal Articles

Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy- 1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease

M Korbling, YO Huh, A Durett, N Mirza, P Miller, H Engel, P Anderlini, K van Besien, M Andreeff, D Przepiorka

Blood (1995) 86 (7): 2842–2848.

https://doi.org/10.1182/blood.V86.7.2842.2842

Published: 1995

NARROW

Prophylaxis of Graft-Versus-Host Disease (GVHD) with Pentostatin, Tacrolimus, and “Mini”-Methotrexate (MTX): A Phase I/II Controlled, Randomized Study in Unrelated Donor (UD) Transplantation.

Higher Rate of Thrombotic Thrombocytopenic Pupura (TTP) Associated with Graft Versus Host Disease (GVHD) and Unrelated Donor Bone Marrow Transplantation (BMT).

Unrelated-Donor PBSC Collection Facilitated by the NMPD, 1999–2005: Efficacy and Toxicities, Serious Unexpected Events, and Outcomes of Standard vs. Large Volume Collections.

Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) with Fludarabine and Melphalan (FM) Reduced Intensity Conditioning (RIC) for High-Risk AML/MDS.

Results of a Phase I/II Study of Gemtuzumab Ozogamicin Added to Fludarabine (F), Melphalan (M) and Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Relapsed Myeloid Leukemias.

Pentostatin, Tacrolimus, and “Mini”-Methotrexate for Graft-Versus-Host Disease (GVHD) Prophylaxis: A Phase I/II Controlled, Randomized Study.

Phase I/II Study of Gemtuzumab Ozogamicin (GO), Fludarabine and Melphalan (FM) Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in AML/MDS.

Peripheral blood stem cell apheresis in normal donors: the neglected side [letter; comment]

Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals

Treatment of chronic myelogenous leukemia: current status and investigational options [see comments]

Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy- 1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only